These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21903938)

  • 1. MicroRNA-29 in aortic dilation: implications for aneurysm formation.
    Boon RA; Seeger T; Heydt S; Fischer A; Hergenreider E; Horrevoets AJ; Vinciguerra M; Rosenthal N; Sciacca S; Pilato M; van Heijningen P; Essers J; Brandes RP; Zeiher AM; Dimmeler S
    Circ Res; 2011 Oct; 109(10):1115-9. PubMed ID: 21903938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.
    Davis FM; Rateri DL; Balakrishnan A; Howatt DA; Strickland DK; Muratoglu SC; Haggerty CM; Fornwalt BK; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):155-62. PubMed ID: 25395615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model.
    Okamura H; Emrich F; Trojan J; Chiu P; Dalal AR; Arakawa M; Sato T; Penov K; Koyano T; Pedroza A; Connolly AJ; Rabinovitch M; Alvira C; Fischbein MP
    Physiol Rep; 2017 Apr; 5(8):. PubMed ID: 28455451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.
    Moltzer E; te Riet L; Swagemakers SM; van Heijningen PM; Vermeij M; van Veghel R; Bouhuizen AM; van Esch JH; Lankhorst S; Ramnath NW; de Waard MC; Duncker DJ; van der Spek PJ; Rouwet EV; Danser AH; Essers J
    PLoS One; 2011; 6(8):e23411. PubMed ID: 21858106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics.
    Orriols M; Varona S; Martí-Pàmies I; Galán M; Guadall A; Escudero JR; Martín-Ventura JL; Camacho M; Vila L; Martínez-González J; Rodríguez C
    Cardiovasc Res; 2016 Jun; 110(3):431-42. PubMed ID: 27089918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miR-195 in aortic aneurysmal disease.
    Zampetaki A; Attia R; Mayr U; Gomes RS; Phinikaridou A; Yin X; Langley SR; Willeit P; Lu R; Fanshawe B; Fava M; Barallobre-Barreiro J; Molenaar C; So PW; Abbas A; Jahangiri M; Waltham M; Botnar R; Smith A; Mayr M
    Circ Res; 2014 Oct; 115(10):857-66. PubMed ID: 25201911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the prospect of serum exosomal miRNA profiling and protein biomarkers for the diagnosis of ascending aortic dilatation in patients with bicuspid and tricuspid aortic valve.
    Gallo A; Agnese V; Coronnello C; Raffa GM; Bellavia D; Conaldi PG; Pilato M; Pasta S
    Int J Cardiol; 2018 Dec; 273():230-236. PubMed ID: 30297190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm.
    Shen M; Lee J; Basu R; Sakamuri SS; Wang X; Fan D; Kassiri Z
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):888-98. PubMed ID: 25657308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.
    Huang J; Davis EC; Chapman SL; Budatha M; Marmorstein LY; Word RA; Yanagisawa H
    Circ Res; 2010 Feb; 106(3):583-92. PubMed ID: 20019329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-126a-5p limits the formation of abdominal aortic aneurysm in mice and decreases ADAMTS-4 expression.
    Li L; Ma W; Pan S; Li Y; Wang H; Wang B; Khalil RA
    J Cell Mol Med; 2020 Jul; 24(14):7896-7906. PubMed ID: 32469162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mediators of aneurysm progression in bicuspid aortic valve disease.
    Tobin SW; Alibhai FJ; Lee MM; Yeganeh A; Wu J; Li SH; Guo J; Tsang K; Tumiati L; Rocha R; Butany J; Yau TM; Ouzounian M; David TE; Weisel RD; Li RK
    J Mol Cell Cardiol; 2019 Jul; 132():71-83. PubMed ID: 31047984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms.
    Palao T; Rippe C; van Veen H; VanBavel E; Swärd K; Bakker EN
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1486-93. PubMed ID: 26968543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
    Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs in aneurysmal aortopathy.
    Spin JM; Li DY; Maegdefessel L; Tsao PS
    Vascul Pharmacol; 2019 Mar; 114():110-121. PubMed ID: 29909014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.
    Verbrugghe P; Verhoeven J; Clijsters M; Vervoort D; Schepens J; Meuris B; Herijgers P
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):215-222. PubMed ID: 29300219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice.
    Hanada K; Vermeij M; Garinis GA; de Waard MC; Kunen MG; Myers L; Maas A; Duncker DJ; Meijers C; Dietz HC; Kanaar R; Essers J
    Circ Res; 2007 Mar; 100(5):738-46. PubMed ID: 17293478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-4 mediates cardiovascular remodelling in angiotensin II-induced hypertension.
    Palao T; Medzikovic L; Rippe C; Wanga S; Al-Mardini C; van Weert A; de Vos J; van der Wel NN; van Veen HA; van Bavel ET; Swärd K; de Waard V; Bakker EN
    Cardiovasc Pathol; 2018; 35():12-19. PubMed ID: 29729633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.